Biocept Inc. (BIOCQ)
OTCMKTS: BIOCQ · Delayed Price · USD
0.0001
0.00 (0.00%)
Mar 25, 2024, 12:00 AM EDT - Market open

Biocept Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2011
Net Income
-32.09-2.82-17.81-25.26-25.21-21.61-18.4-16.95-15.87-9.23
Upgrade
Depreciation & Amortization
2.22.6410.770.80.580.320.260.250.27
Upgrade
Share-Based Compensation
3.232.460.940.870.621.251.591.381.820.95
Upgrade
Other Operating Activities
13.381.42-3.920.450.790.140.790.16-0.781.81
Upgrade
Operating Cash Flow
-13.293.69-19.79-23.05-22.36-19.65-15.7-15.15-14.58-6.2
Upgrade
Capital Expenditures
-0.81-1.57-0.87-0.74-0.15-1.4-0.45-0.17-0.39-0
Upgrade
Investing Cash Flow
-0.81-1.57-0.87-0.74-0.15-1.4-0.45-0.17-0.39-0
Upgrade
Share Issuance / Repurchase
0.2414.1526.628.2625.692113.7719.5517.390.02
Upgrade
Debt Issued / Paid
-2.11-1.77-1.54-0.93-1.92-2.57-1.83-0.772.886.07
Upgrade
Other Financing Activities
--0.662.34-0.15----
Upgrade
Financing Cash Flow
-1.8712.3825.7229.6623.7818.5911.9418.7820.276.09
Upgrade
Net Cash Flow
-15.9714.55.075.881.28-2.46-4.213.465.3-0.12
Upgrade
Free Cash Flow
-14.12.12-20.65-23.78-22.5-21.05-16.15-15.32-14.97-6.2
Upgrade
Free Cash Flow Margin
-54.51%3.46%-75.21%-430.21%-692.26%-415.31%-501.02%-2511.85%-11221.06%-4620.71%
Upgrade
Free Cash Flow Per Share
-24.944.30-52.31-345.36-2412.28-6889.90-15173.53-25010.08-101107.46-921431.07
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).